SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
3.135
+0.085 (2.79%)
Apr 25, 2025, 4:00 PM EDT - Market closed
SOPHiA GENETICS Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for SOPHiA GENETICS stock have an average target of 6.50, with a low estimate of 6.00 and a high estimate of 7.00. The average target predicts an increase of 107.34% from the current stock price of 3.14.
Analyst Consensus: Strong Buy
* Price targets were last updated on Aug 7, 2024.
Analyst Ratings
The average analyst rating for SOPHiA GENETICS stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 1 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $8 → $7 | Buy | Maintains | $8 → $7 | +123.29% | Aug 7, 2024 |
| Guggenheim | Guggenheim | Strong Buy Initiates $6 | Strong Buy | Initiates | $6 | +91.39% | Jun 27, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $8 | Buy | Reiterates | $8 | +155.18% | Mar 6, 2024 |
| BTIG | BTIG | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +155.18% | Mar 6, 2024 |
| RBC Capital | RBC Capital | Buy Reiterates $8 | Buy | Reiterates | $8 | +155.18% | Jan 12, 2024 |
Financial Forecast
Revenue This Year
74.84M
from 65.17M
Increased by 14.83%
Revenue Next Year
91.90M
from 74.84M
Increased by 22.79%
EPS This Year
-0.88
from -0.95
EPS Next Year
-0.73
from -0.88
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 77.9M | 97.9M | 126.0M | ||
| Avg | 74.8M | 91.9M | 120.1M | ||
| Low | 71.1M | 83.9M | 114.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 19.5% | 30.8% | 37.1% | ||
| Avg | 14.8% | 22.8% | 30.7% | ||
| Low | 9.2% | 12.1% | 24.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.79 | -0.67 | -0.38 |
| Avg | -0.88 | -0.73 | -0.50 |
| Low | -0.97 | -0.83 | -0.66 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.